लोड हो रहा है...

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma

Personalized cell therapy targeting tumor antigens with expanded tumor-infiltrating lymphocytes (TILs) has shown great promise in metastatic melanoma (MM) since the 90s. However, MM was first-in line to benefit from the wave of checkpoint inhibitors (CPI), which shifted the focus of immunotherapy al...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Immunother Cancer
मुख्य लेखकों: Borch, Troels Holz, Andersen, Rikke, Ellebaek, Eva, Met, Özcan, Donia, Marco, Marie Svane, Inge
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMJ Publishing Group 2020
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398110/
https://ncbi.nlm.nih.gov/pubmed/32747469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000668
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!